Group One Trading’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Group One Trading’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$141	–	8453
2023 Q2	$141	Hold	100	–	–	﹤0.01%	7492
2023 Q1	$159	Sell	100 -8,327	-99%	-$15.1K	﹤0.01%	7008
2022 Q4	$12.3K	Hold	8,427	–	–	﹤0.01%	5919
2022 Q3	$36K	Sell	8,427 -100	-1%	-$423	﹤0.01%	5669
2022 Q2	$33K	Hold	8,527	–	–	﹤0.01%	5921
2022 Q1	$41K	Buy	8,527 +8,204	+2,540%	+$24.7K	﹤0.01%	6260
2021 Q4	$1K	Hold	323	–	–	﹤0.01%	8052
2021 Q3	$3K	Buy	+323	New	+$3.18K	﹤0.01%	7904
2021 Q1	–	Sell	-2,537	Closed	-$26.4K	–	8125
2020 Q4	$18K	Sell	2,537 -2,625	-51%	-$13.7K	﹤0.01%	5578
2020 Q3	$23K	Buy	5,162 +4,063	+370%	+$35.5K	﹤0.01%	5065
2020 Q2	$10K	Sell	1,099 -388	-26%	-$5.85K	﹤0.01%	5132
2020 Q1	$22K	Buy	1,487 +399	+37%	+$8.66K	﹤0.01%	4188
2019 Q4	$13K	Sell	1,088 -223	-17%	-$3.73K	﹤0.01%	4528
2019 Q3	$33K	Buy	1,311 +26	+2%	+$750	﹤0.01%	4174
2019 Q2	$33K	Buy	1,285 +400	+45%	+$15.5K	﹤0.01%	3984
2019 Q1	$38K	Sell	885 -84	-9%	-$1.9K	﹤0.01%	3703
2018 Q4	$14K	Buy	969 +142	+17%	+$5.79K	﹤0.01%	4164
2018 Q3	$58K	Sell	827 -711	-46%	-$54K	﹤0.01%	3887
2018 Q2	$114K	Sell	1,538 -155	-9%	-$13.8K	﹤0.01%	3473
2018 Q1	$161K	Buy	1,693 +1,144	+208%	+$196K	﹤0.01%	2934
2017 Q4	$71K	Buy	+549	New	+$51.5K	﹤0.01%	3545
2017 Q3	–	Sell	-4	Closed	-$327	–	5240
2017 Q2	$0	Buy	4 +3	+300%	+$344	﹤0.01%	5177
2017 Q1	$0	Sell	1 -411	-100%	-$58.8K	﹤0.01%	5081
2016 Q4	$52K	Sell	412 -57	-12%	-$7.93K	﹤0.01%	3245
2016 Q3	$72K	Hold	469	–	–	﹤0.01%	3128
2016 Q2	$54K	Buy	469 +3	+0.6%	+$332	﹤0.01%	3259
2016 Q1	$53K	Sell	466 -186	-29%	-$28.2K	﹤0.01%	3230
2015 Q4	$123K	Sell	652 -88	-12%	-$16.5K	﹤0.01%	2853
2015 Q3	$126K	Sell	740 -153	-17%	-$55.2K	﹤0.01%	2878
2015 Q2	$564K	Buy	893 +397	+80%	+$211K	0.01%	1676
2015 Q1	$255K	Buy	496 +298	+151%	+$150K	﹤0.01%	2184
2014 Q4	$106K	Buy	+198	New	+$89.2K	﹤0.01%	2799
2014 Q3	–	Sell	-187	Closed	-$271K	–	5528
2014 Q2	$256K	Buy	+187	New	+$217K	﹤0.01%	2181
2014 Q1	–	Sell	-238	Closed	-$277K	–	5654
2013 Q4	$237K	Buy	+238	New	+$246K	﹤0.01%	2286
2013 Q3	–	Sell	-87	Closed	-$93K	–	5661
2013 Q2	$95K	Buy	+87	New	+$96.9K	﹤0.01%	2861

Other funds holding VIRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading's VIRX Position: Q3 2023 in Review

Group One Trading sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q3 2023, closing a stake of 100 shares — an estimated $141 sold.

Group One Trading first reported a position in VIRX in Q2 2013 and held it in 35 quarters. The position peaked at $564K in Q2 2015. 42 funds tracked by Wall St. Rank hold VIRX as of Q3 2023.

Group One Trading reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Group One Trading sold 100 Viracta Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $141.
Group One Trading first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 35 quarters.
Group One Trading's Viracta Therapeutics, Inc. Common Stock position peaked at $564K in Q2 2015.
42 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.